290 related articles for article (PubMed ID: 25011656)
1. Variability of linezolid concentrations after standard dosing in critically ill patients: a prospective observational study.
Zoller M; Maier B; Hornuss C; Neugebauer C; Döbbeler G; Nagel D; Holdt LM; Bruegel M; Weig T; Grabein B; Frey L; Teupser D; Vogeser M; Zander J
Crit Care; 2014 Jul; 18(4):R148. PubMed ID: 25011656
[TBL] [Abstract][Full Text] [Related]
2. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A
Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring: linezolid too?
Richards GA; Brink AJ
Crit Care; 2014 Sep; 18(5):525. PubMed ID: 25673559
[TBL] [Abstract][Full Text] [Related]
4. Linezolid clearance during continuous venovenous hemodiafiltration: a case report.
Kraft MD; Pasko DA; DePestel DD; Ellis JJ; Peloquin CA; Mueller BA
Pharmacotherapy; 2003 Aug; 23(8):1071-5. PubMed ID: 12921253
[TBL] [Abstract][Full Text] [Related]
5. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
[TBL] [Abstract][Full Text] [Related]
6. Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients.
Myrianthefs P; Markantonis SL; Vlachos K; Anagnostaki M; Boutzouka E; Panidis D; Baltopoulos G
Antimicrob Agents Chemother; 2006 Dec; 50(12):3971-6. PubMed ID: 16982782
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Rimmelé T; Djabarouti S; Toutain J; Chassard D; Saux MC; Allaouchiche B
Crit Care Med; 2005 Jul; 33(7):1529-33. PubMed ID: 16003058
[TBL] [Abstract][Full Text] [Related]
8. Removal of linezolid by conventional intermittent hemodialysis, sustained low-efficiency dialysis, or continuous venovenous hemofiltration in patients with acute renal failure.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Sagripanti S; Manini P; Andreoli R; Cabassi A
Crit Care Med; 2004 Dec; 32(12):2437-42. PubMed ID: 15599148
[TBL] [Abstract][Full Text] [Related]
9. Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases.
Pea F; Viale P; Lugano M; Pavan F; Scudeller L; Della Rocca G; Furlanut M
Am J Kidney Dis; 2004 Dec; 44(6):1097-102. PubMed ID: 15558532
[TBL] [Abstract][Full Text] [Related]
10. Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study.
Ehmann L; Zoller M; Minichmayr IK; Scharf C; Maier B; Schmitt MV; Hartung N; Huisinga W; Vogeser M; Frey L; Zander J; Kloft C
Crit Care; 2017 Oct; 21(1):263. PubMed ID: 29058601
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
Alffenaar JW; van Altena R; Harmelink IM; Filguera P; Molenaar E; Wessels AM; van Soolingen D; Kosterink JG; Uges DR; van der Werf TS
Clin Pharmacokinet; 2010 Aug; 49(8):559-65. PubMed ID: 20608757
[TBL] [Abstract][Full Text] [Related]
13. Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration.
De Pascale G; Fortuna S; Tumbarello M; Cutuli SL; Vallecoccia M; Spanu T; Bello G; Montini L; Pennisi MA; Navarra P; Antonelli M
Intensive Care Med; 2015 Jan; 41(1):103-10. PubMed ID: 25413377
[TBL] [Abstract][Full Text] [Related]
14. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Caillault-Sergent A; Djabarouti S; Guillaume C; Xuereb F; Bouvet L; Rimmelé T; Saux MC; Allaouchiche B
J Antimicrob Chemother; 2012 May; 67(5):1207-10. PubMed ID: 22351682
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients.
Dong H; Wang X; Dong Y; Lei J; Li H; You H; Wang M; Xing J; Sun J; Zhu H
Int J Antimicrob Agents; 2011 Oct; 38(4):296-300. PubMed ID: 21741222
[TBL] [Abstract][Full Text] [Related]
16. Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic study.
Cai Y; Chai D; Falagas ME; Karageorgopoulos DE; Wang R; Bai N; Liang B
Expert Opin Investig Drugs; 2013 Mar; 22(3):309-15. PubMed ID: 23360474
[TBL] [Abstract][Full Text] [Related]
17. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
[TBL] [Abstract][Full Text] [Related]
18. Developments in the pharmacokinetic/pharmacodynamic index of linezolid: a step toward dose optimization using Monte Carlo simulation in critically ill patients.
Dong H; Xie J; Chen L; Wang T; Sun J; Zhao Y; Dong Y
Int J Infect Dis; 2014 May; 22():35-40. PubMed ID: 24603161
[TBL] [Abstract][Full Text] [Related]
19. Piperacillin concentration in relation to therapeutic range in critically ill patients--a prospective observational study.
Zander J; Döbbeler G; Nagel D; Maier B; Scharf C; Huseyn-Zada M; Jung J; Frey L; Vogeser M; Zoller M
Crit Care; 2016 Apr; 20():79. PubMed ID: 27039986
[TBL] [Abstract][Full Text] [Related]
20. Target site pharmacokinetics of linezolid after single and multiple doses in diabetic patients with soft tissue infection.
Eslam RB; Burian A; Vila G; Sauermann R; Hammer A; Frenzel D; Minichmayr IK; Kloft C; Matzneller P; Oesterreicher Z; Zeitlinger M
J Clin Pharmacol; 2014 Sep; 54(9):1058-62. PubMed ID: 24677034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
